Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Braz. j. infect. dis ; 16(2): 170-1174, May-Apr. 2012. ilus, tab
Article in English | LILACS | ID: lil-622739

ABSTRACT

OBJECTIVE: Compare the anti-T. gondii IgG titer between HIV-1 infected and non HIV-1 infected pregnant women and report three cases of congenital toxoplasmosis resulting from reactivation of infection during pregnancy of HIV-1 infected women. METHODS: This study was conducted among 2,270 pregnant women with chronic Toxoplasma gondii infection (absence of IgM and presence of IgG), including 82 HIV-1 infected and 2,188 non-infected women. RESULTS: The average anti-T. gondii IgG titer was 127 for the 2,188 non-HIV-1 infected women, and 227 for the 82 HIV-1-infected women (p = 0,007). These results suggested that higher anti-T. gondii IgG titers in HIV-1-infected pregnant women may not be indicative of an elevated risk for fetal infection. In this study three cases of congenital toxoplasmosis that resulted from infection reactivation during pregnancy of HIV-1-infected women were manifested by fetal death, symptomatic infection, and infant without symptoms, respectively. In two of these women, a ten-fold increase in IgG levels above used cutoff was observed (2,320 UI/mL and 3,613 UI/mL, respectively). In the third pregnant women anti-T. gondii IgG titers during pregnancy did not rise despite the occurrence of congenital toxoplasmosis (204; 198; 172 UI/mL). CONCLUSIONS: Congenital toxoplasmosis resulting reactivation of infection during pregnancy in the studied group leads us to believe that it is a public health problem, especially in our population, in which seroprevalence of T. gondii infections is high. These findings also suggest that special attention is necessary during pregnancy, because the serologic diagnosis may not be indicative of toxoplasmosis reactivation.


Subject(s)
Adult , Female , Humans , Infant, Newborn , Pregnancy , Young Adult , AIDS-Related Opportunistic Infections/parasitology , Antibodies, Protozoan/blood , Immunoglobulin G/blood , Pregnancy Complications, Infectious/parasitology , Toxoplasma/immunology , Toxoplasmosis, Congenital/diagnosis , Toxoplasmosis/transmission , AIDS-Related Opportunistic Infections/immunology , Pregnancy Complications, Infectious/immunology , Retrospective Studies , Risk Factors , Toxoplasmosis, Congenital/immunology , Toxoplasmosis/immunology , Viral Load
2.
Arq. bras. cardiol ; 80(3): 311-320, Mar. 2003. tab
Article in Portuguese, English | LILACS | ID: lil-331109

ABSTRACT

OBJECTIVE: Detect of cardiac alterations in children with AIDS and compare their evolution with the administration of only one anti-retroviral and the recent cases who received drugs in combination. METHODS: We prospectively studied 47 children in 3 groups: group 1, 20 cases treated only with zidovudine; group 2, 10 patients treated initially with zidovudine and later with a combination of drugs and in group 3, 17 patients, who receiced two or three since the beginning. In all patients it was done chest X-ray, EKG and echocardiography every 6 months and after death complete pathological study. RESULTS: Among the 45 patients cases 26 (57 percent) were index cases. Malnutrition, diarrhea tachycardia, signs of congestive heart failure, pericardial effusion, abnormal ventricular repolarization and arrhythmias were more frequent in group 1. Echocardiographic abnormalities were present in 10 (50 percent) children of group 1. They were less frequent in the others two groups. In regard to the outcome in group 1, two patients had worsening of sings of cardiomyopaty and 4 died. Cardiac dysfunction in all cases of group 2 and 3 improved with the medication. CONCLUSION:- The children who received combination and their cardiac alterations had more favorable outcome than those who received only one drug


Subject(s)
Humans , Infant , Child, Preschool , Child , Anti-HIV Agents , Heart , Heart Diseases , HIV Infections , Zidovudine , AIDS-Related Opportunistic Infections , Antiretroviral Therapy, Highly Active , Echocardiography , Follow-Up Studies , HIV Infections , Prospective Studies , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL